GSK3β inhibition has been responsible for the therapeutic effect of lithium in a number of diseases, such as acute brain injury, chronic neurodegenerative diseases, neutropenia and so forth [72,73]. This evidence concerns the gene GSK3B and Decreased total neutrophil count.